JERUSALEM, Israel, July 16, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is proud to announce today the results of its previously announced rights offering. The Company has received subscriptions from existing shareholders for all the offered American Depositary Shares ("ADSs") and ordinary shares, being a total of 3,057,466 ADSs and 18,2

GREENSBORO, N.C., July 16, 2019 /PRNewswire/ -- MutantDx announces the awarding of patents for their ultra-sensitive Liquid Biopsy technology by the United States and European Patent Offices. This technology can identify and confirm the minute amounts of DNA cancer mutations liberated into the blood stream, while virtually

ROCKVILLE, Md., July 16, 2019 /PRNewswire/ -- More than 1,000 Maryland prescribers are making more informed prescribing decisions since adopting DrFirst's mobile medical management platform, iPrescribe, to consult the state's prescription drug monitoring program (PDMP) database. DrFirst, the nation's leading provider of e-pres

BURLINGTON, ON, July 16, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. (CSE: DOSE), ("RDT") and Ukraine P

LONDON, July 16, 2019 /PRNewswire/ -- ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announced that it has expanded its intellectual property estate via the grant of a number of key patents covering its exosome technology platform. New patents have recently issued covering ReNeuron's neural stem cell-d

HOLON, Israel, July 16, 2019 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced today that the United States Patent and Trademark Office (USPTO) has granted a new patent covering method of use of COM701, a first-i

SAN JOSE, Calif., July 16, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today an

REHOVOT, Israel, July 16, 2019 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announces today that after achieving positive results, its corn disease resistance research collaboration with the Crop Science Division of Bayer1 is being refocused on the identificat

SOUTHAMPTON, N.Y., July 16, 2019 /PRNewswire/ -- On Saturday, August 3rd, Stony Brook Southampton Hospital will host its 61st

SAN FRANCISCO, July 16, 2019 /PRNewswire/ -- CORA Health Services, Inc., doing business as CORA Physical Therapy ("CORA" or "the Company"), a top-10 national operator of outpatient physical therapy services, announced today that it has expanded its Midwest footprint with the acquisition of Orthopedic and Sports Therapy Institute ("OSTI"). OSTI was founded in 1999